A possible involvement of ion transporter in tumor necrosis factor α and cycloheximide-induced apoptosis of endothelial cells

被引:9
作者
Fujita, H
Morita, I
Murota, S
机构
[1] Tokyo Metropolitan Bokutou Gen Hosp, Dept Internal Med, Sumida Ku, Tokyo 1308575, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol Chem, Bunkyo Ku, Tokyo 113, Japan
关键词
apoptosis; tumor necrosis factor; chloride bicarbonate exchanger; endothelial cells;
D O I
10.1080/09629359990379
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
WE examined the tumor necrosis factor alpha (TNF alpha)induced apoptosis of vascular endothelial cells from the standpoint of ion channels. Cultured vascular endothelial cells from bovine carotid artery were used. Apoptosis was determined by a propidium iodide assay. Treatment of the endothelial cells with TNF alpha and cycloheximide for Gh induced nuclear fragmentation in a TNF alpha dose-dependent manner (1-10 ng/ml). Concomitant treatment of endothelial cells with TNF alpha at a dose of 10 ng/ml and cycloheximide at a dose of 10 mu g/ml elicited endothelial cell apoptosis as high as 23.4+/-4.1% at Gh after administration. However, 10 ng/ml TNF alpha alone elicited a little apoptosis at bh after its administration (% apoptosis=4.1+/-0.8%). Cycloheximide (10 mu g/ml) did not induce apoptosis at all, Concomitant treatment of endothelial cells with 1 mmol/l of 4,4-diisothiocyanatostilbene-2,2-disulfonic acid, which is a chloride bicarbonate exchanger blocker, partially inhibited the TNF alpha and cycloheximide-induced endothelial cell apoptosis, On the other hand, endothelial cell apoptosis due to TNF alpha and cycloheximide was completely inhibited by benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene (50 mu mol/l), an inhibitor of caspase. Moreover, pyrrolidine dithiocarbanate, an inhibitor of nuclear factor kappa B (NF-kappa B), also suppressed endothelial cell apoptosis induced by TNF alpha and cycloheximide completely. These findings suggest that the endothelial cell apoptosis induced by TNF alpha and cycloheximide is closely related to not only chloride ions, but also both NF-kappa B and caspase activation. That is to say, there is a possibility that chloride ions or bicarbonate (pH) may play an important role in signal transduction such as NF-kappa B and caspase activation in the apoptosis induced by TNF alpha and cycloheximide.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 29 条
[1]   ROLE OF PROTEIN-KINASE-C IN THE INHIBITION BY FIBROBLAST GROWTH-FACTOR OF APOPTOSIS IN SERUM-DEPLETED ENDOTHELIAL-CELLS [J].
ARAKI, S ;
SIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) :1081-1085
[2]  
BERGAMASCHI G, 1993, LEUKEMIA, V7, P2012
[3]   PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889
[4]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[5]  
Chen ZP, 1996, BIOCHEM MOL BIOL INT, V38, P607
[6]   Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases [J].
Dimmeler, S ;
Haendeler, J ;
Nehls, M ;
Zeiher, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :601-607
[7]   A POSSIBLE MECHANISM FOR VASCULAR ENDOTHELIAL-CELL INJURY ELICITED BY ACTIVATED LEUKOCYTES - A SIGNIFICANT INVOLVEMENT OF ADHESION MOLECULES, CD11/CD18, AND ICAM-1 [J].
FUJITA, H ;
MORITA, I ;
MUROTA, SI .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 309 (01) :62-69
[8]  
FUKS Z, 1994, CANCER RES, V54, P2582
[9]   REPERFUSION INJURY INDUCES APOPTOSIS IN RABBIT CARDIOMYOCYTES [J].
GOTTLIEB, RA ;
BURLESON, KO ;
KLONER, RA ;
BABIOR, BM ;
ENGLER, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (04) :1621-1628
[10]  
HORIE S, 1993, J PHARMACOL EXP THER, V265, P1313